Position in SNY
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$296,596
-$9,543 QoQ
Shares Held
6,156
-5.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.15%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2023
10 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in SNY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026First Affirmative Financial Network holds $11,800,477 across 12 Drug Manufacturers - General names. SNY ranks #9 (2.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NVS |
Novartis AG
|
12,575 | $1,920,831 | |
| 2 | JNJ |
Johnson & Johnson
|
7,524 | $1,839,166 | |
| 3 | LLY |
ELI LILLY & Co
|
1,848 | $1,699,734 | |
| 4 | AZN |
Astrazeneca PLC
|
7,477 | $1,474,613 | |
| 5 | MRK |
Merck & Co., Inc.
|
10,609 | $1,276,156 | |
| 6 | ABBV |
AbbVie Inc.
|
5,527 | $1,202,067 | |
| 7 | AMGN |
Amgen Inc
|
2,302 | $809,958 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
3,735 | $520,546 |
All Filings in SNY
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $296,596 | 6,156 | Shares | Sole | 2026-05-11 | |
| 2025-09-30 | $306,139 | 6,486 | Shares | Sole | 2025-11-20 | |
| 2025-06-30 | $286,381 | 5,928 | Shares | Sole | 2025-11-20 | |
| 2025-03-31 | $315,844 | 5,695 | Shares | Sole | 2025-04-11 | |
| 2024-12-31 | $269,991 | 5,598 | Shares | Sole | 2025-01-23 | |
| 2024-09-30 | $260,833 | 4,526 | Shares | Sole | 2024-10-10 | |
| 2024-06-30 | $234,157 | 4,826 | Shares | Sole | 2024-07-10 | |
| 2024-03-31 | $219,574 | 4,518 | Shares | Sole | 2024-04-11 | |
| 2023-12-31 | $210,904 | 4,241 | Shares | Sole | 2024-01-08 | |
| 2023-09-30 | $226,468 | 4,222 | Shares | Sole | 2023-10-16 | |
| No filing history on record for this holder in this stock. | ||||||